Gilead life sciences- An American Biopharmaceutical company has announced results of phase 3 trial of an antiviral drug called Remdesivir.. the results found effective...
Earlier USFDA had given an interim Approval based on phase 1/ 2 trial...
It appears until a vaccination is developed, Remdesivir can serve as an interim solution.
(1) One is vaccine as you said everybody anxiously waiting for a preventive and proactive measure!
Hopefully, the vaccine would be successful at one shot..... and approx 8 billion doses would be required to cover the entire world .....
(2) Second is a treatment plan for the ones who are currently sufferring from Covid19 infections...and as of today there is no standard treatment plan... Nations are just having their own trial and error / Hit & miss methods of drug administration ......some country is using HCQS, and some are using a HIV drug/existing anti-viral drug, some one is using Remdesivir and some one is trying with Blood plasma from Antibodies from Covid19 cured person....
So there is a need for a standard treatment plan ... and USFDA seem to have given an interim solution fir Remdesivir based upon human trials by Gilead.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.